Condensed Consolidated Statements of Cash Flow (USD $)	9 Months Ended		140 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Cash Flows From Operating Activities
Net loss	$ (11,100,250)	$ (10,647,282)	$ (129,453,326)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	4,650	4,579	450,616
Amortization of patents	503,340	503,340	7,292,837
Amortization of original issue discount			3,845,721
Amortization of commitment fee			310,866
Amortization of prepaid consultant expense			1,295,226
Amortization of deferred loan costs			2,261,584
Accretion of United States Treasury Bills			(373,295)
Loss on extinguishment of debt			825,867
Loss on exercise of warrants			236,146
Beneficial conversion of convertible interest			55,976
Convertible interest			389,950
Compensation through issuance of stock options	142,310	183,028	14,540,039
Compensation through issuance of stock			932,000
Issuance of stock for services	312,000	409,250	9,365,511
Issuance of warrants for services	1,527,518	1,381,329	7,724,087
Issuance of warrants for contractual obligations			985,010
Gain on sale of equipment			(55,075)
Loss (gain) on change in fair value of warrant liability	917,102	(1,435,898)	(4,995,099)
Change in assets and liabilities
Prepaid expenses and other current assets	(45,284)	(16,284)	(45,284)
Accounts payable	(40,971)	179,513	198,819
Accrued expenses	72,014	1,512,859	489,633
Net cash used in operating activities	(7,707,571)	(7,925,566)	(83,722,191)
Cash Flows From Investing Activities
Proceeds from sale of fixed assets			180,075
Capital expenditures	(6,650)	(15,885)	(96,570)
Proceeds from sales of investments			37,010,481
Purchases of investments			(36,637,186)
Net cash (used in) provided by investing activities	(6,650)	(15,885)	456,800
Cash Flows From Financing Activities
Net proceeds from loans from stockholder			174,000
Proceeds from convertible debt			6,706,795
Net proceeds from sales of preferred stock and warrants	2,550,000		11,458,131
Net proceeds from sales of common stock and warrants	12,204,174	2,077,796	55,018,695
Proceeds from exercises of warrants and stock options	21,000		21,099,014
Cash paid for preferred dividends	(29,063)		(29,063)
Cash paid to retire convertible debt			(2,385,959)
Cash paid for deferred loan costs			(747,612)
Premium paid on extinguishments of debt			(170,519)
Purchase and retirement of common stock			(48,000)
Net proceeds from sale of non-controlling interest in Pure-ific Corporation			443,500
Net cash provided by financing activities	14,746,111	2,077,796	91,518,982
Net change in cash and cash equivalents	7,031,890	(5,863,655)	8,253,591
Cash and cash equivalents, at beginning of period	1,221,701	7,705,773
Cash and cash equivalents, at end of period	$ 8,253,591	$ 1,842,118	$ 8,253,591